Patents by Inventor Mads Ropke

Mads Ropke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100330669
    Abstract: Variants of FVII or FVIIa comprising at least one amino acid modification in position 196, 237, or 341 relative to hFVII or hFVIIa. The variants exhibit an increased clotting activity, i.e. reduced clotting time, compared to rhFVIIa.
    Type: Application
    Filed: May 5, 2010
    Publication date: December 30, 2010
    Inventors: Kim Vilbour Andersen, Mads Röpke, Jesper Mortensen Haaning, Steven Glazer
  • Patent number: 7771996
    Abstract: Variants of FVII or FVIIa comprising at least one amino acid modification in position 196, 237 or 341 relative to hFVII or hFVIIa. The variants exhibit an increased clotting activity, i.e. reduced clotting time, compared to rhFVIIa.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: August 10, 2010
    Assignee: Bayer Healthcare LLC
    Inventors: Kim Vilbour Andersen, Mads Röpke, Jesper Mortensen Haaning, Steven Glazer
  • Publication number: 20080188400
    Abstract: Methods for the treatment of various bleeding disorders using variants of human Factor VII (hFVII) or activated FVII (FVIIa) having an altered activity compared to 5 recombinant FVIIa with the native human sequence.
    Type: Application
    Filed: April 25, 2006
    Publication date: August 7, 2008
    Inventors: Mads Ropke, Stephanie J. Lathrop
  • Publication number: 20070054366
    Abstract: Variants of FVII or FVIIa comprising at least one amino acid modification in position 196, 237 or 341 relative to hFVII or hFVIIa. The variants exhibit an increased clotting activity, i.e. reduced clotting time, compared to rhFVIIa.
    Type: Application
    Filed: March 22, 2004
    Publication date: March 8, 2007
    Applicant: MAXYGEN HOLDINGS LTD.
    Inventors: Kim Andersen, Mads Ropke, Jesper Haaning, Steven Glazer